一、同意中国平安人寿保险股份有限公司新乐支公司将营业场所变更为：河北省石家庄市新乐市市区幸 福路南侧育才街东侧泰和花园临街三层商业14号1-2层。 二、中国平安人寿保险股份有限公司应按照有关规定及时办理变更及许可证换领事宜。 2025年9月29日，河北金融监管局发布批复称，《中国平安（601318）人寿保险股份有限公司河北分公 司关于中国平安人寿保险股份有限公司新乐支公司变更营业场所的请示》（平保寿冀分发〔2025〕257 号）及相关材料收悉。经审核，现批复如下： ...

一、同意中国平安人寿保险股份有限公司贵州分公司将营业场所变更为：贵州省贵阳市观山湖区永昌路 9号29层整层。 二、中国平安人寿保险股份有限公司应按照有关规定及时办理变更及许可证换领事宜。 2025年9月29日，国家金融监督管理总局贵州监管局发布批复称，《关于中国平安（601318）人寿保险 股份有限公司贵州分公司变更营业场所的请示》（平保寿贵分发〔2025〕72号）收悉。经审核，现批复 如下： ...

Core Viewpoint - Zhuhai Yueya Semiconductor Co., Ltd. has submitted its prospectus for an IPO on the Hong Kong Stock Exchange, aiming to raise approximately 1.224 billion yuan for expansion projects and working capital [3][4]. Financial Summary - The company plans to allocate 1.037 billion yuan for the AI-focused high-performance embedded packaging module expansion project, 107 million yuan for the R&D center project, and 80 million yuan for working capital [4]. - In the first half of 2023, Yueya Semiconductor reported a revenue of 811 million yuan [5]. - Projected revenues for 2022, 2023, and 2024 are 1.667 billion yuan, 1.7 billion yuan, and 1.796 billion yuan, respectively, with net profits of 415 million yuan, 188 million yuan, and 215 million yuan [4][5]. Shareholder Structure - The largest shareholder is AMITEC Company, holding 39.9452% of shares, followed by Xin Xin Chuan with 30.9106% [6][9]. - Other notable shareholders include Oriental Fortune Management and Zhuhai Huajin Lingrui, holding 2.221% and 2.7104% respectively [8][9]. Ownership Changes Post-IPO - After the IPO, AMITEC's shareholding will decrease to 33.9535%, while Xin Xin Chuan's will drop to 26.274% [10]. - The total number of shares post-IPO will be approximately 1.049 billion, with the public holding 15% [10].

Core Viewpoint - The guidance issued by the National Financial Regulatory Administration on promoting high-quality development in health insurance is positive and significant for the industry [1] Group 1: Regulatory Developments - The regulatory framework allows insurance companies with good ratings to launch participating dividend-type long-term health insurance products [1] - Implementation details are not finalized, but a transitional solution is expected to involve a combination of dividend savings policies and critical illness riders [1] - The focus remains on the fundamental purpose of protection despite the introduction of dividend features [1] Group 2: Market Implications - The introduction of dividend-type critical illness insurance in mainland China is expected to have limited competitive impact on the insurance sales for mainland visitors in the Hong Kong market, which is developing steadily [1] - Key success factors for dividend health insurance include strong regulatory ratings, investment and distribution capabilities, a focus on protection products, and the establishment of a medical ecosystem [1] Group 3: Company Analysis - The company "Huai Bang China" is identified as a major beneficiary of these developments [1] - Among domestic listed insurance companies, China Ping An (02318) is relatively focused on protection products and possesses a comprehensive online and offline medical ecosystem, which may create synergies with health products like critical illness insurance [1]

Core Viewpoint - UBS reports that the National Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, which is seen as positive and significant [1] Group 1: Regulatory Changes - The guidelines allow insurance companies with good regulatory ratings to launch participating dividend-type long-term health insurance products [1] - Implementation details are not finalized, but a transitional solution is expected to involve a combination of dividend savings policies and critical illness riders [1] - Despite the introduction of dividend features, regulators will continue to focus on the fundamental purpose of protection [1] Group 2: Market Comparison - The introduction of dividend-type critical illness insurance in mainland China is expected to have limited competitive impact on the Hong Kong market for insurance sales to mainland visitors [1] - Hong Kong's dividend products typically offer higher demonstration rates, around 6%-6.5%, compared to mainland rates of 2.9%-3.3% [1] - Hong Kong insurance products provide a broader range of global investment options, catering to the asset diversification needs of visitors [1] Group 3: Key Success Factors - Key success factors for dividend health insurance include strong regulatory ratings, investment and distribution capabilities, a focus on protection products, and the development of a medical ecosystem [1] - Friends Health China is viewed as a major beneficiary of these developments [1] - Among domestic listed insurance companies, China Ping An (02318) is relatively focused on protection products and has a well-established online and offline medical ecosystem, which may create synergies with health products like critical illness insurance [1]

智通财经APP获悉，瑞银发布研报称，国家金融监管总局发布《关于推动健康保险高质量发展》的指导 意见，内容正面且具积极意义。监管评级优良的保险公司获准推出参与分红型长期健康保险产品。实施 细节尚未最终确定，但预期将采用分红储蓄保单+重大疾病附加险的过渡性解决方案。尽管引入分红功 能，监管机构仍将继续聚焦于保障的基本宗旨。 该行认为，内地允许分红型重大疾病险对香港市场的内地访客保险销售竞争有限，香港的分红型重大疾 病险市场发展稳健。首先，香港的分红产品通常提供更高的演示利率例如6%-6.5%，而内地为 2.9%-3.3%。其次，香港保险产品提供更广泛的全球投资选择，满足访港客保险对资产多元化的需求。 瑞银认为，分红健康保险的关键成功因素包括强大的监管评级、投资与分销能力、专注于保障产品以及 医疗生态系统的建设。基于上述因素，看好友邦中国作为主要受惠者。在国内上市保险公司中，中国平 安(02318)相对专注于保障产品。中国平安并拥有完善的线上线下医疗生态系统，可能与健康产品如重 大疾病险产生协同效应。 ...

| 成交量 （万 | 成交金 | 成交价 | 相对当日收盘 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | | 额（万 | 格 | 折溢价（%） | | | | 股） | 元） | （元） | | | | | 36.25 | 1997.74 | 55.11 | 0.00 | 广发证券股份有限公司 广州康王中路证券营业 | 中国国际金融股份有限公司北 京建国门外大街证券营业部 | | | | | | 部 | | | 25.00 | 1377.75 | 55.11 | 0.00 | 招商证券股份有限公司 | 广发证券股份有限公司总部 | | | | | | 北京景辉街证券营业部 | | | 25.00 | 1377.75 | 55.11 | 0.00 | 招商证券股份有限公司 | 广发证券股份有限公司总部 | | | | | | 北京景辉街证券营业部 | | 进一步统计，近3个月内该股累计发生8笔大宗交易，合计成交金额为3.30亿元。 （文章来源：证券时报网） 证券时报·数据宝统计显示，中国平安今日收盘价为55.11元，下跌1.61%，日换手率为 ...

第2笔成交价格为55.11元，成交25.00万股，成交金额1,377.75万元，溢价率为0.00%，买方营业部为招 商证券股份有限公司北京景辉街证券营业部，卖方营业部为广发证券股份有限公司总部。 第3笔成交价格为55.11元，成交36.25万股，成交金额1,997.74万元，溢价率为0.00%，买方营业部为广 发证券股份有限公司广州康王中路证券营业部，卖方营业部为中国国际金融股份有限公司北京建国门外 大街证券营业部。 进一步统计，近3个月内该股累计发生8笔大宗交易，合计成交金额为3.3亿元。该股近5个交易日累计上 涨0.16%，主力资金合计净流出3.43亿元。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 9月30日，中国平安收跌1.61%，收盘价为55.11元，发生3笔大宗交易，合计成交量86.25万股，成交金 额4753.24万元。 第1笔成交价格为55.11元，成交25.00万股，成交金额1,377.75万元，溢价率为0.00%，买方营业部为招 商证券股份有限公司北京景辉街证券营业部，卖方营业部为广发证券股份有限公司总部。 责任编辑：小浪快报 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中国平安保险（集团）股份有限公司 呈交日期: 2025年9月30日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | A | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 601318 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 10,762,657,695 | RMB | | 1 | RMB | | 10,762,657,695 | | 增加 / 減少 (-) | | | -102,592,612 | | | | RMB | | -102,592,612 | | 本月底結存 | | | 10,660,065,083 | RMB | | 1 | ...

9月30日，中国平安大宗交易成交86.25万股，成交额4753.24万元，占当日总成交额的1.11%，成交价 55.11元，较市场收盘价55.11元持平。 | 交易日期 | 证券简称 | 证券代码 | | | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | 卖出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-09-30 | 中国平安 | 81318 | 55.11 | 1997.74 | 36.25 | 公司 浏览量高 | | 服 | | 2025-09-30 | 中国早安 | 601318 | 55.11 | 1377.75 | ટે | 想到了了解 | 公营营业的有限 | 194 | | 2025-09-30 | 中国零安 | 601318 | 55.11 | 1377.75 | રેન્ટે | 想是需要的体 | 么答复塑胶的有限 | 중 | ...